Clinical Trials on Epstein-Barr Virus Infections in Argentina

Total 328 results

Laboratorios Roemmers S.A.I.C.F.

Unknown

Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)

COVID-19

Argentina
Anaconda Pharma

Completed

Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts

Human Papillomavirus Infection | Condylomata Acuminata | Anogenital Warts

Argentina, France
Sanofi Pasteur, a Sanofi Company

Completed

Safety of a Second Dose of Biken's Varicella Vaccine

Varicella

Argentina
Fundacion Infant

Completed

Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection

Covid19 | Pregnancy Related | Neonatal Infection

Argentina
Hospital de Clinicas José de San Martín
SILVATEAM

Terminated

Tannin Specific Natural Extract for COVID-19 Infection (TanCOVID)

COVID-19 | Coronavirus Infection | SARS-CoV 2

Argentina
ViiV Healthcare
GlaxoSmithKline

Completed

Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.

Infection, Human Immunodeficiency Virus

Argentina
Química Luar SRL
National Council of Scientific and Technical Research, Argentina; Centro de...

Unknown

Inhaled Ibuprofen to Treat COVID-19 (CórdobaTrail)

Coronavirus Infection | Respiratory Disease | SARS (Disease)

Argentina
Hospital Italiano de Buenos Aires

Completed

Severe Impairment of Solute-Free Water Clearance in Patients With HIV Infection

HIV Infection

Argentina
Hospital Nacional Profesor Alejandro Posadas

Completed

HYPONATREMIA IN COVID-19 PATIENTS

Covid19 | Corona Virus Infection | Hyponatremia

Argentina
Novartis Pharmaceuticals

Terminated

Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection (REVERT)

Recurrent Hepatitis C

Argentina
University of Buenos Aires
Merck Sharp & Dohme LLC

Completed

Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population

Condylomata Acuminata

Argentina
Sanatorio Anchorena San Martin

Completed

Healthcare-associated Infections in Severe COVID-19 During 2020 (COVIACS)

COVID-19 | Respiration, Artificial | Health Care Associated Infection

Argentina
RFS Pharma, LLC

Terminated

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.

Human Immunodeficiency Virus Infection

Argentina
Administracion Nacional de Laboratorios e Institutos...

Recruiting

Safety and Effectiveness of an Immunobiological Drug in CoViD-19 (INPB001)

Covid19 | COVID-19 Pneumonia | COVID-19 Respiratory Infection

Argentina
Laboratorio Elea Phoenix S.A.
China National Biotec Group Company Limited; Beijing Institute of Biological... and other collaborators

Completed

Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)

COVID-19 Virus Infection

Argentina
MedImmune LLC

Completed

Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524

Respiratory Syncytial Virus Infections

Chile, Argentina
Fundación Huésped
Ministerio de Salud de Ciudad Autónoma de Buenos Aires; Laboratorios Roemmers...

Recruiting

Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts (PENTZ)

Covid19 | SARS-CoV-2 Infection | Households Contacts

Argentina
Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES

COVID-19

Argentina
Pedro Cahn
Abbott

Completed

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects. (GARDEL)

HIV Infection

Argentina
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

HIV Infections

Argentina
AbbVie (prior sponsor, Abbott)
Fundasamin (Argentina)

Completed

A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America

Respiratory Syncytial Virus Infection

Argentina, Chile, Colombia, Ecuador, Mexico, Peru, Uruguay
University of Miami
National Institute of Mental Health (NIMH); Fundacion Huesped, Buenos Aires... and other collaborators

Completed

Positive Connections: COPA2

Human Immunodeficiency Virus

Argentina
Ministry of Public Health, Argentina

Completed

Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC) (IVERNEX-TUC)

Covid19

Argentina
Instituto de Cardiología de Corrientes

Completed

Ivermectin to Prevent Hospitalizations in COVID-19 (IVERCORCOVID19)

Covid19

Argentina
Takeda

Not yet recruiting

A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Argentina

Cytomegalovirus (CMV)

Argentina
Laboratorio Elea Phoenix S.A.

Terminated

Recurrent and Nonrecurrent Condyloma Treatment

Recurrent Condyloma | Nonrecurrent Condyloma

Argentina
Sanofi

Completed

A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19

Corona Virus Infection

Mexico, Argentina, Brazil, Chile, Russian Federation
Hospital de Infecciosas Francisco Javier Muniz

Completed

Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma

Covid19 | SARS-CoV Infection | SARS-Associated Coronavirus

Argentina
Asociacion Latinoamericana de Torax

Completed

COVID19 Hospitilized in Clinica Pasteur of Neuquen (Argentina) (COVIDPas)

COVID-19

Argentina
Hospital Italiano de Buenos Aires
Hospital de Niños R. Gutierrez de Buenos Aires; Salud Comunitaria Ministerio...

Completed

Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina

SARS-CoV-2

Argentina
Eurnekian Public Hospital

Completed

USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 (IVERCAR)

Covid19

Argentina
Fernando Saldarini
Hospital de Infecciosas Francisco Javier Muniz; Universidad Nacional de la... and other collaborators

Completed

COVID-19 Sequelae: Treatment and Monitoring. A Dietary Supplement Based on Sea Urchin Eggs With Echinochroma A

Long COVID

Argentina
Novartis
Novartis Vaccines

Completed

Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old

Influenza

Argentina
Hospital General de Niños Pedro de Elizalde

Completed

Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital

Telehealth

Argentina
Hospital Italiano de Buenos Aires
National Agency for Scientific and Technological Promotion, Argentina

Unknown

Liver Transplantation and Coronavirus Disease 2019 (COVID-19)

Covid19 | Liver Transplant

Argentina
Centro de Educación Medica e Investigaciones Clínicas...

Completed

Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia

Covid19 Pneumonia

Argentina
Ministry of Public Health, Argentina

Completed

Ivermectin Reproposing for Mild Stage COVID-19 Outpatients (IVER-Leve)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Argentina
Maria de los Angeles Peral de Bruno

Completed

Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan (Ivercar-Tuc)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

Argentina
Sanatorio Finochietto

Completed

Tocilizumab in Covid-19 Penumonia in Buenos Aires City

COVID-19 Pneumonia | Tocilizumab

Argentina
RFS Pharma, LLC

Completed

Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV

HIV Infections

Argentina
Estudios Clínicos Latino América
Population Health Research Institute

Completed

The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. (COLCOVID)

COVID-19

Argentina
Hospital Italiano de Buenos Aires
Ministerio de Salud de Ciudad Autónoma de Buenos Aires

Completed

Safety of the Sputnik V Vaccine in Health Personnel of Private Effectors of the City of Buenos Aires, Argentina (COVID-19)

COVID-19

Argentina
Fundación Huésped
CanSino Biologics Inc.; Canadian Center for Vaccinology; Hospital Fernandez

Recruiting

Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in Adults 18 Years of Age and Older. (COVID-19)

Covid19

Argentina
Pedro Cahn
Merck Sharp & Dohme LLC

Terminated

Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

HIV Infections

Argentina
Austral University, Argentina

Unknown

Re-linkage to Care of Patients With Hepatitis C

Viral Hepatitis C

Argentina
Estudios Clínicos Latino América
Amarin Pharma Inc.

Completed

PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial (PREPARE-IT)

COVID19

Argentina
Hospital de Niños R. Gutierrez de Buenos Aires

Not yet recruiting

Congenital Cytomegalovirus: Prevalence in Buenos Aires City (cCMV Prevalence) (cCMV)

Congenital Cytomegalovirus

Argentina
Eurnekian Public Hospital

Completed

Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19 (IDEA)

Severe Acute Respiratory Syndrome | Ventilation Pneumonitis

Argentina
Tiva Group

Unknown

Use of the Nasal Cannula During COVID-19

COVID 19

Argentina
Laboratorio Elea Phoenix S.A.

Completed

Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.

Acquired Immunodeficiency Syndrome

Argentina

Clinical Trials on Epstein-Barr Virus Infections in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations